$0.2290
-0.26-53.56%
al cierre: Nov 20, 4:00 PM EST
$0.2342
0.00522.27%
After hour: 7:50 PM EST

Aprea Therapeutics (APRE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-0.09 | $-0.08 | -12.5 % |
| Q2 | Aug 12, 2026 | $-0.07 | $-0.22 | 68.2 % |
| Q1 | May 13, 2026 | $-0.22 | $-0.23 | 4.35 % |
| Q4 | Mar 16, 2026 | $-0.32 | $-0.37 | 13.5 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $0 | $124.00K | -100.0 % |
| Q2 | Aug 12, 2026 | $0 | $203.20K | -100.0 % |
| Q4 | Mar 25, 2025 | $205.82K | $450.00K | -54.3 % |
| Q3 | Nov 7, 2024 | $354.62K | $225.00K | 57.6 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.08 | $-0.22 | $-0.23 | $-0.37 |
| Actual | $-0.09 | $-0.07 | $-0.22 | $-0.32 |
| Surprise | -12.5% | +68.2% | +4.35% | +13.5% |
| Revenue | ||||
| Estimate | $124000 | $203200 | — | — |
| Actual | $0 | $0 | $0 | $3337 |
| Surprise | -100.0% | -100.0% | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.10 | $-0.12 | $-0.08 | $-0.08 |
| Revenue | ||||
| Consensus | $148000 | — | — | — |